Literature DB >> 21576817

Quantitative diffusion weighted MRI: a functional biomarker of nodal disease in Hodgkin lymphoma?

Shonit Punwani1, Vineet Prakash, Alan Bainbridge, Stuart A Taylor, Steven Bandula, Oystein E Olsen, Sharon F Hain, Ananth Shankar, Stephen Daw, Paul Humphries.   

Abstract

PURPOSE: This study explores the relationship between MRI Apparent Diffusion Coefficient (ADC) and PET Standardized Uptake Value (SUV) measurements in pediatric Hodgkin lymphoma.
METHODS: Sixteen patients (mean age 15.4 yrs, 8 male) with proven Hodgkin lymphoma were recruited and staged using PET-CT, anatomical MRI and additional 1.5T diffusion weighted imaging (DWI) prior to and following chemotherapy. Pre-treatment lymph nodes and anatomically paired post-treatment residual tissue located on MRI were matched to the corresponding PET-CT. Region of interest (ROI) analysis was used to extract quantitative measurements. Mean ADC (ADC(mean)) and maximum SUV (SUV(max)) were recorded and correlation assessed using Spearman statistics.
RESULTS: Fifty-three ROIs were sampled. Pre- and post-treatment ADC(mean) ranged from 0.77 × 10(−3) to 1.79 × 10(−3) (median 1.15 × 10(−3) mm(2)s(−1)) and 1.08 × 10(−3) to 3.18 ×10(−3) (median 1.88 × 10(−3) mm(2)s(−1)), and SUV(max) from 2.60 to 25.4 (median 8.85 mg/ml) and 1.00 to 3.50 mg/ml (median 1.90 mg/ml). Median post-treatment ADC(mean) was higher, and median SUV(max) lower than pretreatment values (p < 0.0001). There was an inverse correlation between pre-treatment ADC(mean) and SUV(max) (p = 0.005) and between fractional change ([post-treatment – pre-treatment]/pre-treatment)in ADC(mean) and SUV(max) (p =0.002).
CONCLUSION: Our results confirm a strong reciprocal relationship between nodal ADC(mean) and SUV(max) in Hodgkin lymphoma;supporting the potential application of quantitative DWI as a functional biomarker of disease.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21576817     DOI: 10.3233/CBM-2010-0197

Source DB:  PubMed          Journal:  Cancer Biomark        ISSN: 1574-0153            Impact factor:   4.388


  17 in total

1.  Influence of selected b values on ADC quantification in diffusion-weighted MRI. Comment on Punwani et al.: Diffusion-weighted MRI of lymphoma: prognostic utility and implications for PET/MRI?

Authors:  Adriano M Priola; Sandro M Priola
Journal:  Eur J Nucl Med Mol Imaging       Date:  2013-03-29       Impact factor: 9.236

2.  Comparison of PET/MRI With PET/CT in the Evaluation of Disease Status in Lymphoma.

Authors:  Asim Afaq; Francesco Fraioli; Harbir Sidhu; Simon Wan; Shonit Punwani; Shih-Hsin Chen; Oguz Akin; David Linch; Kirit Ardeshna; Jonathan Lambert; Kenneth Miles; Ashley Groves; Irfan Kayani
Journal:  Clin Nucl Med       Date:  2017-01       Impact factor: 7.794

Review 3.  The role of FDG-PET in defining prognosis of Hodgkin lymphoma for early-stage disease.

Authors:  Andrew M Evens; Lale Kostakoglu
Journal:  Blood       Date:  2014-11-27       Impact factor: 22.113

4.  Evolution of lymphoma staging and response evaluation: current limitations and future directions.

Authors:  Joel Cunningham; Sunil Iyengar; Bhupinder Sharma
Journal:  Nat Rev Clin Oncol       Date:  2017-06-13       Impact factor: 66.675

5.  Whole-body MRI for initial staging of paediatric lymphoma: prospective comparison to an FDG-PET/CT-based reference standard.

Authors:  Annemieke S Littooij; Thomas C Kwee; Ignasi Barber; Claudio Granata; Malou A Vermoolen; Goya Enríquez; József Zsíros; Shui Yen Soh; Bart de Keizer; Frederik J A Beek; Monique G Hobbelink; Marc B Bierings; Jaap Stoker; Rutger A J Nievelstein
Journal:  Eur Radiol       Date:  2014-02-23       Impact factor: 5.315

6.  Correlation of tumor characteristics derived from DCE-MRI and DW-MRI with histology in murine models of breast cancer.

Authors:  Stephanie L Barnes; Anna G Sorace; Mary E Loveless; Jennifer G Whisenant; Thomas E Yankeelov
Journal:  NMR Biomed       Date:  2015-08-30       Impact factor: 4.044

7.  Diffusion-weighted MRI of lymphoma: prognostic utility and implications for PET/MRI?

Authors:  Shonit Punwani; Stuart A Taylor; Ziauddin Z Saad; Alan Bainbridge; Ashley Groves; Stephen Daw; Ananth Shankar; Steve Halligan; Paul D Humphries
Journal:  Eur J Nucl Med Mol Imaging       Date:  2012-11-30       Impact factor: 9.236

8.  Correlations between functional imaging markers derived from PET/CT and diffusion-weighted MRI in diffuse large B-cell lymphoma and follicular lymphoma.

Authors:  Xingchen Wu; Hannu Pertovaara; Pasi Korkola; Prasun Dastidar; Ritva Järvenpää; Hannu Eskola; Pirkko-Liisa Kellokumpu-Lehtinen
Journal:  PLoS One       Date:  2014-01-15       Impact factor: 3.240

9.  18F-Fluorodeoxyglucose Positron Emission Tomography/Magnetic Resonance in Lymphoma: Comparison With 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography and With the Addition of Magnetic Resonance Diffusion-Weighted Imaging.

Authors:  Chiara Giraudo; Markus Raderer; Georgios Karanikas; Michael Weber; Barbara Kiesewetter; Werner Dolak; Ingrid Simonitsch-Klupp; Marius E Mayerhoefer
Journal:  Invest Radiol       Date:  2016-03       Impact factor: 6.016

Review 10.  Whole-body MRI in paediatric oncology.

Authors:  Rutger A J Nievelstein; Annemieke S Littooij
Journal:  Radiol Med       Date:  2015-12-02       Impact factor: 3.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.